The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Thanks for info.
It will be interesting how they order the drills. In terms of cos/risk. Whether they will go largest 1st etc.
Maybe going safest first (if there is such a thing).
I've watched few interviews etc and they seem keen to keep market updated on drill progress when it starts. Any "shows" in drilling to be announced etc.
Having been invested in a few drill programs like this before I'm sure it will get exciting...
Trying to catch up on all the info here.
They're going for 3 drills. Have they confirmed the 3 targets or is that what the seismic they are doing now will confirm?
New placing shares hit 22/4? So assume we might get news on seismic/survey results next week?
It does look like growth.
But also the terminology used in JDs points to consolidating existing/ongoing relationships and building further.
Maybe phase 2 has morphed into something different now, but it still sounds to me that it is v much game on.
I keep coming back to the jobs available...
Read the job descriptions for:-
Field Application Specialist
Senior Territoy Account managers
Strategic Sales Director
And it looks highly likely that Novacyt are still heavily embedded and selling products into the NHS across the UK.
Quite interesting, on Novacyt website there are 2 different job descriptions for senior Territory account managers. Subtly different. One of them talks about the 'ongoing adoption.' The word ongoing is key imo....
"Reporting to the Regional Sales Manager for North/South UK, you will be responsible for managing a group of pathology networks and / or accounts in the NHS. Implementing robust sales strategy to achieve the highest amount of revenue for the business and the on-going adoption and expansion of our product pipeline."
All in all, the terminology in these JDs point to strong existing contracts and sales, and looking to build further.
https://twitter.com/NovacytGroup/status/1377271217632247809?s=19
Interesting that Novacyt retweeted this, considering we are all wondering if they are involved....
Must be seen as good that there was no RNS today.
If they see this quite big news as not RNS worthy, then they must have bigger fish to fry.
A bit like the £10 mill contracts with no RNS.
Any other aim company would be all over this for an RNS, but not Novacyt....are they purposely keeping a lid on the SP, or just quietly and surely going about their business and waiting for the market to catch up?
I feel that 2 things are still not taken into account here with SP.
a) that covid and testing is going to be around for long time.
b) with the above, Novacyt will be able to use that platform to cross sell lots of other products.
What will be the trigger for people to realise this? A more positive forward looking statement?
https://www.gov.uk/government/news/government-reintroduces-confirmatory-pcr-testing?utm_medium=email&utm_campaign=govuk-notifications&utm_source=b1dff0f0-e38a-467a-9718-9d675fe13167&utm_content=immediately
"we have backed new technology, known ‘genotype assay testing’"
Probably doesn't mean a lot, but I have noticed quite a few of the staff that joined in oct 2020 to help with nhs roll out have moved up a level in jan/Feb this year.
Not long now to wait to find out what all this recruitment drive is about.